Barclays Issues Positive Forecast for Envista (NYSE:NVST) Stock Price

Envista (NYSE:NVST) had its price objective raised by Barclays from $24.00 to $34.00 in a research note released on Wednesday morning,Benzinga reports. They currently have an overweight rating on the stock.

A number of other equities analysts have also weighed in on NVST. Evercore reiterated an “outperform” rating and issued a $32.00 price target on shares of Envista in a report on Friday, February 6th. Wells Fargo & Company boosted their price target on Envista from $21.00 to $26.00 and gave the company an “equal weight” rating in a research report on Friday, February 6th. Wall Street Zen upgraded Envista from a “buy” rating to a “strong-buy” rating in a report on Monday, January 26th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Envista in a research note on Monday, December 29th. Finally, Stifel Nicolaus set a $31.00 price target on shares of Envista in a research report on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $27.43.

Envista Trading Down 1.5%

Shares of NVST stock traded down $0.45 during mid-day trading on Wednesday, hitting $29.81. 211,918 shares of the company’s stock were exchanged, compared to its average volume of 3,221,457. The stock has a market cap of $4.90 billion, a price-to-earnings ratio of 107.74, a PEG ratio of 2.06 and a beta of 1.01. The company has a quick ratio of 2.04, a current ratio of 2.38 and a debt-to-equity ratio of 0.47. Envista has a fifty-two week low of $14.22 and a fifty-two week high of $30.42. The stock has a 50-day simple moving average of $23.36 and a two-hundred day simple moving average of $21.43.

Envista (NYSE:NVST) last released its earnings results on Thursday, February 5th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.32 by $0.06. Envista had a return on equity of 6.54% and a net margin of 1.73%.The firm had revenue of $750.60 million for the quarter, compared to the consensus estimate of $680.26 million. During the same period in the prior year, the business posted $0.24 earnings per share. The firm’s revenue for the quarter was up 15.0% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Equities analysts expect that Envista will post 1 EPS for the current fiscal year.

Insider Buying and Selling at Envista

In other Envista news, SVP Mischa Reis sold 9,675 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total value of $290,250.00. Following the transaction, the senior vice president owned 32,382 shares of the company’s stock, valued at $971,460. This trade represents a 23.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.66% of the stock is currently owned by corporate insiders.

Institutional Trading of Envista

Several large investors have recently added to or reduced their stakes in the business. Parallel Advisors LLC boosted its position in Envista by 13.1% during the 4th quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock worth $69,000 after acquiring an additional 367 shares during the period. Sepio Capital LP lifted its stake in shares of Envista by 1.2% in the 4th quarter. Sepio Capital LP now owns 31,632 shares of the company’s stock worth $687,000 after acquiring an additional 374 shares during the period. Deutsche Bank AG boosted its holdings in shares of Envista by 2.9% in the fourth quarter. Deutsche Bank AG now owns 17,412 shares of the company’s stock valued at $378,000 after acquiring an additional 484 shares in the last quarter. GAMMA Investing LLC raised its holdings in Envista by 34.3% during the third quarter. GAMMA Investing LLC now owns 2,498 shares of the company’s stock worth $51,000 after purchasing an additional 638 shares in the last quarter. Finally, Assetmark Inc. lifted its position in Envista by 1.4% in the fourth quarter. Assetmark Inc. now owns 46,273 shares of the company’s stock worth $1,005,000 after purchasing an additional 659 shares during the period.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.